image

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Filing date Description Form View

Statement of changes in beneficial ownership of securities

4 View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A View HTML

Additional proxy soliciting materials - definitive

DEFA14A View HTML

Report of unscheduled material events or corporate event

8-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Securities offered to employees pursuant to employee benefit plans

S-8 View HTML

Report of unscheduled material events or corporate event

8-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.